# Daniel Nadler

> Daniel J. Nadler is a Canadian entrepreneur, poet and visual artist based in Miami Beach. He cofounded Kensho, an AI analytics company acquired by S&P Global in 2018, and later cofounded OpenEvidence, a research search platform for physicians. His poetry collection Lacunae appeared in 2016.

- **Role:** Cofounder and CEO at OpenEvidence
- **Organizations:** OpenEvidence, Kensho Technologies, Academy of American Poets, Whitney Museum of American Art Digital Art Committee, MoMA PS1, EDO
- **From:** Toronto, Canada
- **Nationality:** Canadian
- **Education:** Bachelor of Arts, University of Toronto, PhD, Harvard University
- **Known for:** Cofounded Kensho, acquired by S&P Global in 2018., Published Lacunae in 2016; the book was included in NPR’s Best Books of 2016., Became the youngest person elected to the Academy of American Poets board, according to the academy.

## Career timeline

- **2013** — Cofounded Kensho Technologies while a Harvard PhD student.
- **2014** — Discussed his manuscript of imagined ancient poems and his work at Kensho in a Boston Review interview.
- **2016** — Published Lacunae with Farrar, Straus and Giroux; completed his Harvard PhD.
- **2018** — Kensho was acquired by S&P Global; Nadler joined the Academy of American Poets board.
- **2020** — Joined the Whitney Museum digital art committee.
- **2021** — Joined the board of MoMA PS1.
- **2022** — Cofounded OpenEvidence with Zachary Ziegler.
- **2025** — Named to TIME100 Health; OpenEvidence announced a $75 million Series A and later a $210 million Series B.
- **2026** — OpenEvidence announced a $250 million January round at a $12 billion valuation and a further $250 million September round at a reported $15 billion valuation.

## Achievements

- Cofounded Kensho, acquired by S&P Global in 2018.
- Published Lacunae in 2016; the book was included in NPR’s Best Books of 2016.
- Became the youngest person elected to the Academy of American Poets board, according to the academy.
- Named to the 2025 TIME100 Health list.
- Cofounded OpenEvidence, valued at a reported $15 billion after a September 2026 financing.

## Latest updates

- **2026-09** — OpenEvidence raised $250 million at a reported $15 billion valuation; Nadler confirmed the financing and lead investors to Becker’s Hospital Review.
- **2026-01** — OpenEvidence raised $250 million at a $12 billion valuation; Nadler discussed building an orchestra of specialized models.
- **2025-05** — TIME included Nadler in its TIME100 Health list.

## Links

- Website: https://www.danielnadlerworkshop.com/
- LinkedIn: https://www.linkedin.com/in/danielnadler
- Twitter/X: https://x.com/danielnadler
- Facebook: https://www.facebook.com/daniel.nadler

---

Profile page: https://yespress.io/daniel-nadler
Published by YesPress — https://yespress.io
Last updated: 2026-09-29